Identiv (NASDAQ:INVE) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below.
Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more.
Access the full call at https://ir.identiv.com/webcast-registration?event_id=35548
Summary
Identiv Inc reported first quarter 2026 sales of $7.4 million, exceeding guidance and showing strong demand from existing and new customers.
The company completed the transition to its Thailand manufacturing facility, improving gross margins significantly from the previous year.
Strategic initiatives include the exclusive supply agreement with IFCO and the development of BLE Smart Labels, with mass production expected in Q4 2026.
Identiv Inc’s outlook for Q2 2026 anticipates sales between $5.4 to $6.0 million, reflecting a pull-forward of orders and some demand softening in consumer-facing sectors.
Management highlighted strong progress in strategic initiatives, including a robust pipeline for new product developments and a targeted approach to expanding customer relationships.
Full Transcript
Tom (Operator)
Good afternoon. Welcome to Identiv’s presentation of its first quarter 2026 earnings call. My name is Tom and I will be your operator this afternoon. Joining us for today’s presentation are the Company’s CEO Kirsten Newquist and CFO Ed Kernbauer. Following Management’s remarks, we will open the call for questions. Before we begin, please note that during this call management may be making references to non-GAAP financial measures or guidance including non-GAAP adjusted ebitda, non-GAAP gross profit, non-GAAP gross Margin and non-GAAP operating expenses. In addition, during the call Management will be making forward looking statements. Any statement that refers to expectations, projections or other characteristics of future events, including future financial results, future business and market conditions and opportunities, strategic partnerships and collaborations, and any related benefits and attributes and future plans, strategies, opportunities and goals is a forward looking statement. Actual results may differ materially from those expressed in these forward looking statements. For more information, please refer to the risk factors discussed in documents filed from time to time with the SEC, including the company’s 2025 Annual Report on Form 10-K as amended and the first quarter 2026 Form 10-Q which will be filed with the SEC in the future. Identiv Inc assumes no obligation to update these forward looking statements. I will now turn the call over to CEO Kirsten Newquist for her comments. Ms. Newquist, please proceed.
Kirsten Newquist (Chief Executive Officer)
Thank you operator and thank you all for joining us for our first quarter 2026 earnings conference call. I will begin with a few highlights from the first quarter as we continue to build strong momentum executing against our perform, accelerate and Transform strategy. As discussed on our last call, we achieved a significant milestone by signing a long term agreement with IFCO to exclusively supply BLE Smart Labels for use on their pool of more than 400 million reusable plastic containers. Since then we have been focused on development activities and expect to begin production for over half a million pilot units shortly with mass production anticipated to start in the fourth quarter of this year. We also made meaningful progress at our Thailand Manufacturing facility which is now fully transitioned from Singapore. This facility is increasing our ability to serve our customers more efficiently and at lower costs while continuing to deliver high levels of product quality and service reflected in the positive feedback we are receiving from customers. In addition, we are continuing to grow our opportunity pipeline, particularly for Identiv ID Blue, our portfolio of BLE Smart Labels for asset tracking and logistics applications. We are seeing strong and growing interest across multiple industries including global logistics, pharmaceuticals and food distributors, and we remain on track to make these products commercially available later in the year. Turning to our first quarter financial performance, I’m pleased to report that first quarter sales of 7.4 million exceeded our guidance with other key financial metrics coming in as expected. As anticipated, we saw a slight decline in gross margin versus the fourth quarter given the product mix and some additional scale up costs for a new customer. We expect to see some margin improvement throughout the year as our operations become more efficient, but we will also have some offsetting costs in the second half due to the scale up of IFCO. We are starting to see some impact from the current macroeconomic environment, primarily in our consumer facing applications where demand for higher end products has softened. At the same time certain suppliers have implemented price increases. We are assessing and will be taking pricing actions to offset these costs while continuing to focus on delivering value to our customers and maintaining our margin profile. Our CFO Ed Kernbauer will now provide a detailed review of our first quarter financial performance and afterwards I’ll share more on our progress across our strategic initiatives.
Ed Kernbauer (Chief Financial Officer)
Thanks Kirsten in the first quarter of 2026 we delivered $7.4 million in revenue which exceeded our previously announced guidance range compared to $5.3 million in Q1 2025. The year over year increase was as expected and included strong demand from current customers, the conversion of new customers and the benefit of one of our larger customers ordering their full year 2026 sales volume in Q1 first quarter GAAP and non GAAP gross margins were 17.4% and 23.8% respectively compared to GAAP and non GAAP gross margins of 2.5% and 10.8% respectively in Q1 2025. The primary factor driving the improvement in gross margin was the transition of production to our state of the art Thailand production facility. This included cost savings and efficiencies achieved in procurement and production, improved facility utilization and the elimination of manufacturing production costs from our Singapore operation in Q1 of 2025. In addition, the gross margin improvement year over year also reflected the benefit from charges recorded in Q1 2020 to cost of revenue related to the write down of obsolete inventory at our Singapore facility of 0.3 million and a warranty claim from one of our customers of 0.2 million. GAAP and non GAAP operating expenses for the first quarter of 2026 including research and development, sales and marketing, general and administrative expenses and restructuring and severance totaled 5.5 million 4.4 million respectively as compared to 5.6 million and 4.5 million respectively in Q1 2025. The year over year decrease in GAAP operating expenses was driven primarily by lower restructuring and severance expenses, partially offset by higher strategic review related costs incurred in Q1 of 2026 compared to the first quarter of 2025. Non GAAP operating expenses in Q1 2026 were comparable to the prior year period, demonstrating our continued disciplined allocation of operating expenses as we execute on our PAT strategic initiatives. First quarter GAAP net loss was 3.4 million or $0.15 per basic and diluted share compared to GAAP Net loss of 4.8 million or $0.21 per basic and diluted share in the first quarter of 2025. This improvement in net loss was primarily due to the increase in sales volume in Q1 2026, lower restructuring and severance costs and as mentioned, the impact of charges to cost of revenue of approximately 0.5 million in the first quarter of 2025. Non GAAP adjusted EBITDA loss for Q1 2026 was $2.7 million compared to 3.9 million in the first quarter of 2025. As mentioned, the decreased loss was the result of production efficiencies achieved at our Thailand facility, charges to cost of revenue in Q1 of 2025 and the disciplined spending of operating expenses as we continue to execute on our PAT strategic initiatives. In the appendix of today’s presentation, we have provided a full reconciliation of GAAP to non GAAP financial information which is also included in our earnings release. Moving now to the balance sheet, we exited Q1 2026 with $124.8 million in cash, cash equivalents and restricted cash. Our balance sheet position remains strong with working capital exiting Q1 of 1. $29.6 million. In our 10-Q filing, we will be providing a full reconciliation of year to date cash flows for completeness, we’ve included the full balance sheet in the appendix of today’s earnings release. Finally, I would like to discuss our financial outlook for the second quarter of 2026. We anticipate sales of 5.4 to 6.0 million. As discussed, Q1 sales demonstrated strong growth driven in part by a Significant Full Year 2026 Customer Order placed early to secure product availability. As such, our Q2 sales guidance reflects the pull forward of this volume into Q1. Additionally, the projection incorporates some uncertainty related to softening demand trends among certain consumer facing customers. As mentioned on our March call, we do expect to see margin improvement throughout 2026 as our …
This post was originally published here
